Cargando…
Reduced expression of SMAD4 in gliomas correlates with progression and survival of patients
BACKGROUND: To examine the expression of SMAD4 at gene and protein levels in glioma samples with different WHO grades and its association with survival. METHODS: Two hundreds fifty-two glioma specimens and 42 normal control tissues were collected. Immunochemistry assay, quantitative real-time PCR an...
Autores principales: | He, Shi-ming, Zhao, Zhen-wei, Wang, Yuan, Zhao, Ji-pei, Wang, Liang, Hou, Fang, Gao, Guo-dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3160899/ https://www.ncbi.nlm.nih.gov/pubmed/21791112 http://dx.doi.org/10.1186/1756-9966-30-70 |
Ejemplares similares
-
Expression of HAUSP in gliomas correlates with disease progression and survival of patients
por: CHENG, CHUANDONG, et al.
Publicado: (2013) -
Targeting long non-coding RNA PVT1/TGF-β/Smad by p53 prevents glioma progression
por: Li, Zhang, et al.
Publicado: (2022) -
RhoT1 and Smad4 Are Correlated with Lymph Node Metastasis and Overall Survival in Pancreatic Cancer
por: Jiang, Hua, et al.
Publicado: (2012) -
Melatonin attenuates hypoxia-induced epithelial-mesenchymal transition and cell aggressive via Smad7/ CCL20 in glioma
por: Chen, Xueran, et al.
Publicado: (2017) -
A study of Smad4, Smad6 and Smad7 in Surgically Resected Samples of Pancreatic Ductal Adenocarcinoma and Their Correlation with Clinicopathological Parameters and Patient Survival
por: Singh, Puneet, et al.
Publicado: (2011)